A Shortage Of Some Drugs In Europe During The Coronavirus
January 22nd, 2022
Against the background of the coming fifth COVID wave in our country, the problem of a shortage of vital medicines continues. According to doctors and pharmacists, it is due to their increased consumption in patients with coronavirus, but other groups of patients find it difficult to access therapy, commented bTV.
After a long struggle to get pregnant, Joanna Evtimova and her husband are expecting their first child in about 4 months. However, due to a condition called thrombophilia, the expectant mother needs low-molecular-weight heparin therapy. They have been missing in pharmacies for some time. The injections she currently has will not last until the end of her pregnancy.
The drug is also used in many diseases. However, it is especially complicated for pregnant women – for them, alternatives for other patients are not allowed due to the shortage.
Pharmacists remind us that this problem has existed since the beginning of the COVID epidemic in our country. The Ministry of Health reports that the consumption of low-molecular-weight heparins has jumped more than 5 times.
For the drug “Fraxiparin” deliveries were restored from January 20. By the end of the month, over 60,000 packages in various dosages will be imported. Due to shortages, its exports have been suspended.
Imports of “Clexan” took place on January 14. The quantities are distributed among hospitals and pharmacies. From the answer we received from the Ministry of Health, it is clear that the ratio in the distribution depends largely on the number of hospitalized patients.